Diagnostic accuracy of stress-only myocardial perfusion SPECT improved by deep learning
Abstract
PURPOSE: Deep convolutional neural networks (CNN) for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has been used to improve the diagnostic accuracy of coronary artery disease (CAD). This study was to design and evaluate a deep learning (DL) approach to automatic diagnosis of myocardial perfusion abnormalities from stress-only MPI.
METHODS: The new DL approach developed for this study was compared to a conventional quantitative perfusion defect size (DS) method. A total of 37,243 patients (51.5% males) undergone stress 99mTc-Tetrofosmin or 99mTc-Sestamibi MPI were selected retrospectively from Yale New Haven Hospital. Patients were dichotomized as studies with normal (75.4%) or abnormal (24.6%) myocardial perfusion based on final diagnoses of clinical nuclear cardiologists. Stress myocardial perfusion defect size was calculated using Yale quantitative analytic software. A deep CNN was trained using the circumferential count profile maps derived from SPECT MPI and was evaluated for the diagnosis of perfusion abnormality with a 5-fold cross-validation approach. In each fold, 27,933, 1862 and 7448 patients were used as training, validation and testing datasets, respectively. The area under the receiver-operating characteristic curve (AUC) was calculated and analyzed for all patients as well as for the eight sub-groups classified based on patient genders, quantitative algorithms, radioactive tracers and SPECT cameras.
RESULTS: The AUC…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 37,243 participants or records.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- In silico toxicology protocols
- Automated in Silico Design of Homogeneous Catalysts
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.